Physician
Advanced Allergy and Asthma of Virginia
Advanced Allergy and Asthma of Virginia was paid $877K by Medicaid between May 2018 and Dec 2024, across 12 billing codes. Its largest line is 95004, Percutaneous tests with allergenic extracts, immediate type reaction — 32% of everything it billed.
33Billing provider infoADVANCED ALLERGY AND ASTHMA OF VIRGINIA
MIDLOTHIAN, VA 23112
MIDLOTHIAN, VA 23112
33aNPI1104157114assigned 01/15/2010
33bProvider typeAllergy Physician
28Total paid$877K
24GClaims20,746
24DCodes billed12
24AFirst – last monthMay 2018 – Dec 2024
Compared with peers
Next to other Allergy Physician providers in Virginia
Rank by total paid#3 of 13
Median peer was paid$125K
This provider vs. median7.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 510 | $23K | |
| 2019 | 1,920 | $88K | |
| 2020 | 1,761 | $56K | |
| 2021 | 2,877 | $113K | |
| 2022 | 3,995 | $185K | |
| 2023 | 5,821 | $253K | |
| 2024incomplete | 3,862 | $159K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 32% | 2,256 | 2,112 | $280K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 2,890 | 2,627 | $153K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | 14% | 395 | 269 | $121K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 1,431 | 1,335 | $107K |
| 95117 | 9.9% | 10,002 | 3,273 | $87K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.2% | 426 | 413 | $46K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.1% | 625 | 583 | $45K |
| 95115 | 1.5% | 2,101 | 652 | $14K | |
| 96401 | 1.5% | 282 | 145 | $13K | |
| 95024 | <1% | 161 | 150 | $9K | |
| 94010 | <1% | 160 | 147 | $3K | |
| J2357 | Injection, omalizumab, 5 mg | 0% | 17 | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFEINSTEIN, BARRY (PRESIDENT)